Form 4: Cyclo Therapeutics Director Vivien Wong Receives Stock Grant in Lieu of Cash Compensation

Director Vivien Wong of Cyclo Therapeutics, Inc. received 25,140 shares of common stock as compensation in lieu of cash.

Summary

• Vivien Wong, a director at Cyclo Therapeutics, Inc., received 25,140 shares of common stock on February 27, 2025.
• The shares were granted as compensation in lieu of cash under the company's non-employee director compensation policy.
• This grant covers director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025.
• The number of shares was calculated based on a closing price of $0.77 per share on February 26, 2025.
• Following the transaction, Wong directly owns 64,853 shares of Cyclo Therapeutics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. A director taking stock instead of cash can be seen as a positive sign of confidence, but it's a relatively small transaction and part of a pre-existing compensation plan.

Positives

• The director's decision to take stock in lieu of cash compensation could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Directors accepting stock in lieu of cash is a common practice, especially in smaller companies, to conserve cash and align director interests with shareholders.

Stakeholder Impact

• The stock grant dilutes existing shareholders slightly.

Key Dates